Wave Life Sciences WVE Operating Cash Flow
Operating Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Wave Life Sciences in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities.
The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →
Ask your AI about Wave Life Sciences's operating cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Wave Life Sciences's operating cash flow?
- Wave Life Sciences (WVE) reported operating cash flow of -$59.55M in Q1 2026.
- How has Wave Life Sciences's operating cash flow changed year-over-year?
- Wave Life Sciences's operating cash flow increased by 5.5% year-over-year, from -$63.04M to -$59.55M.
- What is the long-term trend for Wave Life Sciences's operating cash flow?
- Over 3 years (2021 to 2025), Wave Life Sciences's operating cash flow has grown at a 28.2% compound annual growth rate (CAGR), from -$88.99M to -$187.49M.
- What does operating cash flow mean?
- Total cash generated by or used in core business operations — the single most important cash flow metric for assessing business health.